Utah Medical Products (UTMD) Competitors $57.36 +0.33 (+0.58%) As of 06/12/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock UTMD vs. CERS, OSUR, ANIK, WST, COO, ALGN, MMSI, HAE, ICUI, and XRAYShould you be buying Utah Medical Products stock or one of its competitors? The main competitors of Utah Medical Products include Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), ICU Medical (ICUI), and DENTSPLY SIRONA (XRAY). These companies are all part of the "health care supplies" industry. Utah Medical Products vs. Its Competitors Cerus OraSure Technologies Anika Therapeutics West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems Haemonetics ICU Medical DENTSPLY SIRONA Cerus (NASDAQ:CERS) and Utah Medical Products (NASDAQ:UTMD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, community ranking, dividends, risk and analyst recommendations. Does the MarketBeat Community favor CERS or UTMD? Cerus received 416 more outperform votes than Utah Medical Products when rated by MarketBeat users. Likewise, 72.34% of users gave Cerus an outperform vote while only 61.60% of users gave Utah Medical Products an outperform vote. CompanyUnderperformOutperformCerusOutperform Votes57072.34% Underperform Votes21827.66% Utah Medical ProductsOutperform Votes15461.60% Underperform Votes9638.40% Does the media prefer CERS or UTMD? In the previous week, Cerus had 6 more articles in the media than Utah Medical Products. MarketBeat recorded 8 mentions for Cerus and 2 mentions for Utah Medical Products. Utah Medical Products' average media sentiment score of 1.43 beat Cerus' score of 1.14 indicating that Utah Medical Products is being referred to more favorably in the news media. Company Overall Sentiment Cerus Positive Utah Medical Products Positive Which has more risk & volatility, CERS or UTMD? Cerus has a beta of 1.55, indicating that its share price is 55% more volatile than the S&P 500. Comparatively, Utah Medical Products has a beta of 0.27, indicating that its share price is 73% less volatile than the S&P 500. Do insiders and institutionals have more ownership in CERS or UTMD? 78.4% of Cerus shares are owned by institutional investors. Comparatively, 69.6% of Utah Medical Products shares are owned by institutional investors. 5.6% of Cerus shares are owned by company insiders. Comparatively, 7.4% of Utah Medical Products shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts recommend CERS or UTMD? Cerus presently has a consensus target price of $3.50, indicating a potential upside of 155.47%. Given Cerus' stronger consensus rating and higher probable upside, equities research analysts plainly believe Cerus is more favorable than Utah Medical Products.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Utah Medical Products 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is CERS or UTMD more profitable? Utah Medical Products has a net margin of 33.92% compared to Cerus' net margin of -11.60%. Utah Medical Products' return on equity of 11.07% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets Cerus-11.60% -40.55% -11.12% Utah Medical Products 33.92%11.07%10.53% Which has better valuation and earnings, CERS or UTMD? Utah Medical Products has lower revenue, but higher earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCerus$185.14M1.41-$37.49M-$0.10-13.70Utah Medical Products$39.27M4.74$13.87M$3.7815.17 SummaryCerus and Utah Medical Products tied by winning 9 of the 18 factors compared between the two stocks. Get Utah Medical Products News Delivered to You Automatically Sign up to receive the latest news and ratings for UTMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UTMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UTMD vs. The Competition Export to ExcelMetricUtah Medical ProductsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$186.31M$4.37B$5.61B$8.62BDividend Yield2.18%42.67%5.28%4.17%P/E Ratio14.5228.2927.2119.96Price / Sales4.7470.02408.49157.63Price / Cash9.5951.0838.2534.64Price / Book1.625.827.074.69Net Income$13.87M$67.63M$3.23B$248.14M7 Day Performance2.14%-1.03%0.68%0.91%1 Month Performance4.84%16.63%9.59%5.71%1 Year Performance-14.85%18.79%32.02%14.71% Utah Medical Products Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UTMDUtah Medical Products2.6067 of 5 stars$57.36+0.6%N/A-14.2%$186.31M$39.27M14.52180Positive NewsDividend AnnouncementCERSCerus2.607 of 5 stars$1.32+3.9%$3.50+165.2%-25.5%$252.33M$185.14M-12.00290Positive NewsAnalyst RevisionOSUROraSure Technologies3.2954 of 5 stars$2.85-1.0%$3.00+5.3%-35.3%$213.18M$161.63M19.00840Positive NewsANIKAnika Therapeutics4.2248 of 5 stars$11.45+2.7%$20.00+74.7%-56.8%$164.20M$117.05M-1.72300Positive NewsWSTWest Pharmaceutical Services4.7808 of 5 stars$209.43-0.7%$332.50+58.8%-33.5%$15.05B$2.90B31.3010,700Trending NewsCOOCooper Companies3.2808 of 5 stars$67.00-1.9%$100.38+49.8%-25.2%$13.40B$3.93B34.3614,000High Trading VolumeALGNAlign Technology4.7159 of 5 stars$178.51-1.3%$241.25+35.1%-31.7%$12.94B$3.98B31.8223,200Positive NewsMMSIMerit Medical Systems4.225 of 5 stars$93.64-1.5%$109.11+16.5%+12.4%$5.53B$1.39B45.906,850Positive NewsHAEHaemonetics4.0586 of 5 stars$68.78+1.6%$97.89+42.3%-17.1%$3.30B$1.36B27.082,820ICUIICU Medical4.612 of 5 stars$130.54-3.2%$192.67+47.6%+14.1%$3.21B$2.42B-28.5614,500XRAYDENTSPLY SIRONA4.7051 of 5 stars$15.62-2.3%$20.36+30.4%-40.8%$3.11B$3.72B-7.5515,000 Related Companies and Tools Related Companies Cerus Alternatives OraSure Technologies Alternatives Anika Therapeutics Alternatives West Pharmaceutical Services Alternatives Cooper Companies Alternatives Align Technology Alternatives Merit Medical Systems Alternatives Haemonetics Alternatives ICU Medical Alternatives DENTSPLY SIRONA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UTMD) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Utah Medical Products, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Utah Medical Products With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy UTMD Stock Free UTMD Stock Alerts